Success Stories: NIW Petition Approved for a Scientist II from India in the Field of Bioanalytical Chemistry
Client’s Testimonial:
“Thank you for the fantastic news! It was a pleasure to work with the Chen team.”
On February 5th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist II in the Field of Bioanalytical Chemistry (Approval Notice).
General Field: Bioanalytical Chemistry
Position at the Time of Case Filing: Scientist II
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: February 5th, 2025
Processing Time: 27 days (Premium Processing Requested)
Case Summary:
Based on the huge number of successful cases, North America Immigration Law Group has developed the most up-to-date winning strategies for the NIW category, which enable us to offer our “Approval or Refund” services to many of the NIW cases we take. However, there are certain prerequisites to be fulfilled by an individual including:
- The foreign national must be in a position to advance the proposed endeavor.
- The applicant must present evidence that the U.S. would benefit on balance to waive the job offer criteria for an EB-2.
- A proposed endeavor, holding substantial merit and national importance.
Our client, a Scientist II from India approached us to file an NIW (National Interest Waiver Petition) on his behalf.
He has completed his Ph.D. in molecular biosciences and as an expert in the field of bioanalytical chemistry, his proposed endeavor is to continue his research on developing advanced metabolomics and multiomics tools to comprehensively characterize the gut microbiome and create pioneering live biotherapeutic drugs to target infections caused by antimicrobial-resistant bacteria, an area of research of clear substantial merit and national importance.
Therefore, to make a persuasive case in his favor, we included the following details in his petition packet:
- His work has resulted in 9 peer-reviewed journal articles (5 of them first-authored).
- His publications have been cited a total of 351 times according to Google Scholar.
- He has conducted at least 10 reviews to date.
Furthermore, his research advancing his proposed endeavor addresses the need for more effective antimicrobial therapeutics. By uncovering critical biomarkers correlated with antimicrobial resistance, and by advancing live biotherapeutic solutions, our client is directly mitigating this prominent public health challenge. Therefore, his work is necessary for enhancing therapeutic efficacy and saving human lives.
On that account, he received his NIW approval in 27 days only with our team’s efforts and the Premium Processing Service. We are pleased to have been a part of his success story and would like to wish him good luck in his upcoming endeavors.

